The findings support the fact that further extension of nationwide cardiovascular disease (CVD) risk identification programs and prevention strategies to reduce the occurrence of cardiovascular diseases are warranted
Confirmed positive phase 3 topline results in addition to Enavogliflozin monotherapy and Metformin combination therapy
This advanced technology for Diabetic Foot Ulcer (DFU), management has a high scope of preventing amputations in diabetic patients. It has no definitive treatment in India. This technology will be available at affordable rates
The aim is to create an awareness programme that will drive diabetic patients to get their eyes tested regularly
A total of 12 generic medicines have been included in the list
Remote screening of diabetic retinopathy can help in early detection, even before there are any noticeable vision changes
The trial, dubbed MALBEC, marks the first in a broader late-phase development push for MK-8748, with a second NVAMD study expected to begin later this year
Eylea 2mg (intravitreal aflibercept injection) is an anti-VEGF therapy that blocks a protein responsible for abnormal blood vessel growth and leakage in the retina
Sugammadex injection is bioequivalent to Merck’s Bridion injection for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adults and pediatric patients aged 2 years and older undergoing surgery
It promises fewer injections for vision loss patients
Subscribe To Our Newsletter & Stay Updated
